Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) is now available.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has provided an update regarding the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd. As of the latest update, there have been no significant developments in the bankruptcy proceedings that could impact the company’s financial position. The company remains committed to monitoring the situation closely, maintaining communication with relevant parties, and safeguarding the interests of its shareholders.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products.
Find detailed analytics on 2TZ stock on TipRanks’ Stock Analysis page.